Defence Therapeutics Provides Corporate Update as Company Executes on Strategic Priorities

Montreal, Quebec--(. - September 28, 2026) - Defence Therapeutics Inc. CSE:DTC (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® platform, is pleased to…